Xinyue Deng

Key Laboratory Of Pathobiology
Changchun, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

The Nrf2/PGC1α Pathway Regulates Antioxidant and Proteasomal Activity to Alter Cisplatin Sensitivity in Ovarian Cancer.

The Nrf2/PGC1α Pathway Regulates Antioxidant and Proteasomal Activity to Alter Cisplatin Sensitivity in Ovarian Cancer.

Journal: Oxidative medicine and cellular longevity

Published: July 28, 2020

Polyphyllin VII induces mitochondrial apoptosis by regulating the PP2A/AKT/DRP1 signaling axis in human ovarian cancer.

Polyphyllin VII induces mitochondrial apoptosis by regulating the PP2A/AKT/DRP1 signaling axis in human ovarian cancer.

Journal: Oncology reports

Published: May 11, 2020

p53 Affects PGC1α Stability Through AKT/GSK-3β to Enhance Cisplatin Sensitivity in Non-Small Cell Lung Cancer.

p53 Affects PGC1α Stability Through AKT/GSK-3β to Enhance Cisplatin Sensitivity in Non-Small Cell Lung Cancer.

Journal: Frontiers in oncology

Published: March 12, 2020

Correction to: PKM2, function and expression and regulation.

Correction to: PKM2, function and expression and regulation.

Journal: Cell & bioscience

Published: June 27, 2019

PKM2, function and expression and regulation.

PKM2, function and expression and regulation.

Journal: Cell & bioscience

Published: March 06, 2019

Pyruvate dehydrogenase kinase 1 interferes with glucose metabolism reprogramming and mitochondrial quality control to aggravate stress damage in cancer.

Pyruvate dehydrogenase kinase 1 interferes with glucose metabolism reprogramming and mitochondrial quality control to aggravate stress damage in cancer.

Journal: Journal of Cancer

Published: February 22, 2019

Enzymatic determination of uric acid using water-soluble CuInS/ZnS quantum dots as a fluorescent probe.

Enzymatic determination of uric acid using water-soluble CuInS/ZnS quantum dots as a fluorescent probe.

Journal: Mikrochimica acta

Published: May 31, 2018

ABT737 reverses cisplatin resistance by targeting glucose metabolism of human ovarian cancer cells.

ABT737 reverses cisplatin resistance by targeting glucose metabolism of human ovarian cancer cells.

Journal: International journal of oncology

Published: November 07, 2017

Showing 1-8 of 8

Last Updated: 09/26/2026